Piper Sandler Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $93

Moomoo NewsNov 5 07:35 ET · Ratings

Piper Sandler Remains a Buy on Structure Therapeutics, Inc. Sponsored ADR (GPCR)

TipRanksNov 5 06:58 ET · Ratings

Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek 2024

GlobeNewswireOct 31 08:30 ET

Top Small-cap Stock Picks From Morgan Stanley Following the Group's Upgrade to Neutral

Seeking AlphaOct 21 14:52 ET

BMO Capital Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $100

Moomoo NewsOct 21 08:31 ET · Ratings

Consumer, Labor Groups Urge FTC to Block Catalent Sale to Novo Nordisk - Report

Seeking AlphaOct 17 15:30 ET